子宫内膜癌术后患者报告结局:前哨淋巴结定位与淋巴结清扫下肢淋巴水肿患病率比较
本研究对2006年1月至2012年12月接受初次手术的子宫内膜癌患者于2016年8月邮寄包含13项下肢淋巴水肿筛查问卷的调查,比较前哨淋巴结定位(SLN)与全面淋巴结清扫(LND)后患者报告的下肢淋巴水肿患病率。599例可评估患者中,SLN组180例、LND组352例、单纯子宫切除67例。SLN组自报下肢淋巴水肿患病率为27%(49/180),LND组为41%(144/352),校正体外 Beam 放疗和体重指数后LND仍与下肢淋巴水肿患病率升高独立相关(OR 1.8,95%CI 1.22-2.69,P=0.003)。
要点
- SLN定位组患者报告下肢淋巴水肿患病率27%(49/180),低于LND组的41%(144/352)。
- 校正EBRT和BMI后,LND与下肢淋巴水肿患病率升高独立相关(OR 1.8,95%CI 1.22-2.69,P=0.003)。
- 接受EBRT者下肢淋巴水肿患病率51%(23/45),未接受者为35%(170/487)。
核心结论
- 这是首项评估子宫内膜癌SLN定位后患者报告下肢淋巴水肿的研究。
- SLN定位与患者报告下肢淋巴水肿患病率显著降低独立相关。
- 高BMI和辅助EBRT与患者报告下肢淋巴水肿患病率升高相关。
研究设计与样本
- 对2006年1月至2012年12月接受初次手术的子宫内膜癌患者,于2016年8月邮寄包含经验证的13项下肢淋巴水肿筛查问卷进行调查。
- 排除术前已诊断下肢淋巴水肿及回答问卷条目≤6项者。
- 1275例潜在参与者中623例(49%)回复,599例可评估(SLN组180例、LND组352例、单纯子宫切除67例)。
主要发现
- SLN组自报下肢淋巴水肿患病率27%(49/180),LND组41%(144/352),OR 1.85(95%CI 1.25-2.74,P=0.002)。
- 接受EBRT者下肢淋巴水肿患病率51%(23/45),未接受者35%(170/487),OR 1.95(95%CI 1.06-3.6,P=0.03)。
- 高BMI与下肢淋巴水肿患病率升高相关(OR 1.04,95%CI 1.02-1.06,P=0.001)。
- 校正EBRT和BMI后,LND与下肢淋巴水肿患病率升高独立相关(OR 1.8,95%CI 1.22-2.69,P=0.003)。
- 自报下肢淋巴水肿患者的生活质量显著差于无自报下肢淋巴水肿者。
关键数值与推荐
- SLN组自报下肢淋巴水肿患病率27%(49/180),LND组41%(144/352),OR 1.85(95%CI 1.25-2.74,P=0.002)。
- 接受EBRT者下肢淋巴水肿患病率51%(23/45),未接受者35%(170/487),OR 1.95(95%CI 1.06-3.6,P=0.03)。
- 高BMI与下肢淋巴水肿患病率升高相关(OR 1.04,95%CI 1.02-1.06,P=0.001)。
- 校正EBRT和BMI后,LND与下肢淋巴水肿患病率升高独立相关(OR 1.8,95%CI 1.22-2.69,P=0.003)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the prevalence of patient-reported lower-extremity lymphedema (LEL) with sentinel lymph node (SLN) mapping versus comprehensive lymph node dissection (LND) for the surgical management of newly diagnosed endometrial carcinoma. METHODS: Patients who underwent primary surgery for endometrial cancer from 01/2006-12/2012 were mailed a survey that included a validated 13-item LEL screening questionnaire in 08/2016. Patients diagnosed with LEL prior to surgery and those who answered ≤6 survey items were excluded. RESULTS: Of 1275 potential participants, 623 (49%) responded to the survey and 599 were evaluable (180 SLN, 352 LND, 67 hysterectomy alone). Median BMI was similar among cohorts (P = 0.99). External-beam radiation therapy (EBRT) was used in 10/180 (5.5%) SLN and 35/352 (10%) LND patients (P = 0.1). Self-reported LEL prevalence was 27% (49/180) and 41% (144/352), respectively (OR, 1.85; 95% CI, 1.25-2.74; P = 0.002). LEL prevalence was 51% (23/45) in patients who received EBRT and 35% (170/487) in those who did not (OR, 1.95; 95% CI, 1.06-3.6; P = 0.03). High BMI was associated with increased prevalence of LEL (OR, 1.04; 95% CI, 1.02-1.06; P = 0.001). After controlling for EBRT and BMI, LND retained independent association with an increased prevalence of LEL over SLN (OR, 1.8; 95% CI, 1.22-2.69; P = 0.003). Patients with self-reported LEL had significantly worse QOL compared to those without self-reported LEL. CONCLUSIONS: This is the first study to assess patient-reported LEL after SLN mapping for endometrial cancer. SLN mapping was independently associated with a significantly lower prevalence of patient-reported LEL. High BMI and adjuvant EBRT were associated with an increased prevalence of patient-reported LEL.
引用
- Leitao MM, Zhou QC, Gomez-Hidalgo NR, et al. Patient-reported outcomes after surgery for endometrial carcinoma: Prevalence of lower-extremity lymphedema after sentinel lymph node mapping versus lymphadenectomy. Gynecol Oncol. 2019. PMID: 31780238. doi:10.1016/j.ygyno.2019.11.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。